In the present study, we perform a comprehensive study to validate MTHFD2 as an anticancer target and develop potent MTHFD2 inhibitors to be used as tools to explore the mechanism of action of MTHFD2 in cancer, as well as to demonstrate their therapeutic potential. The gene discussed is MTHFD2; the disease is cancer.